Pharmacist prescriptive authority continues to increase at the state level in the United States. Recently, the Idaho Board of Pharmacy (BOP) finalized regulations that expanded autonomous prescriptive authority in its state to a range of preventative care as well as acute and chronic conditions. This manuscript reviews the key decision points made by the BOP regarding drug categories included, education requirements, protocols, access to data, and use of standards of care. Overall, Idaho's approach closely reflects the medical model of regulation and may prove useful to other states and jurisdictions as they consider similar issues.
Keywords: advanced pharmacy practice; pharmacist prescriptive authority; scope of practice.